A Study to Describe the Safety Profile and Compare the Immune Response of 4 Differents Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

Condition:   Tetanus Immunisation Diphtheria Immunisation Pertussis Immunisation (Healthy Volunteers) Interventions:   Biological: Investigational Tdap vaccine Formulation B;   Biological: Investigational Tdap vaccine Formulation C;   Biological: Investigational Tdap vaccine Formulation A;   Biological: Investigational Tdap vaccine Formulation D;   Biological: Licensed Tdap vaccine Sponsor:   Sanofi Pasteur, a Sanofi Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials